Latest Articles
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology
Safety and Optimal AE Management of Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology
Published: Dec. 22, 2025, 1:15 p.m.
AstraZeneca Starts Phase 3 Post-Surgery Endometrial Cancer Trial - marketscreener.com
AstraZeneca Starts Phase 3 Post-Surgery Endometrial Cancer Trial marketscreener.com
Published: Dec. 22, 2025, 11:40 a.m.
ENHERTU Gets Tenth Breakthrough Therapy Designation, Launches Phase 3 Trial In Endometrial Cancer - Nasdaq
ENHERTU Gets Tenth Breakthrough Therapy Designation, Launches Phase 3 Trial In Endometrial Cancer Nasdaq
Published: Dec. 22, 2025, 11:34 a.m.
Improving the performance of polymerase chain reaction for microsatellite instability testing in endometrial cancer - Nature
Improving the performance of polymerase chain reaction for microsatellite instability testing in endometrial cancer Nature
Published: Dec. 22, 2025, 10:55 a.m.
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer By Investing.com - Investing.com South Africa
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer By Investing.com Investing.com South Africa
Published: Dec. 22, 2025, 8:15 a.m.
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - The AI Journal
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer The AI Journal
Published: Dec. 22, 2025, 7:31 a.m.
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - itemonline.com
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer itemonline.com
Published: Dec. 22, 2025, 7:30 a.m.
Adjuvant Chemoradiotherapy Provides Long-Term Survival Benefits in High-Risk Endometrial Cancer - OncLive
Adjuvant Chemoradiotherapy Provides Long-Term Survival Benefits in High-Risk Endometrial Cancer OncLive
Published: Dec. 22, 2025, 5:26 a.m.
New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial - geneonline.com
New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial geneonline.com
Published: Dec. 21, 2025, 12:34 p.m.
Fruquintinib and Sintilimab Treat Advanced Endometrial Cancer - Bioengineer.org
Fruquintinib and Sintilimab Treat Advanced Endometrial Cancer Bioengineer.org
Published: Dec. 21, 2025, 11:59 a.m.
Link copied to clipboard!